J L Moretti
Overview
Explore the profile of J L Moretti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hindie E, Champion C, Zanotti-Fregonara P, Rubello D, Moretti J
Eur J Nucl Med Mol Imaging
. 2009 Apr;
36(6):1015-6.
PMID: 19399498
No abstract available.
2.
Zanotti-Fregonara P, Hindie E, Faugeron I, Moretti J, Ravasi L, Rubello D, et al.
Minerva Endocrinol
. 2008 Oct;
33(4):313-27.
PMID: 18923368
Differentiated thyroid cancer, when adequately treated, has an overall good prognosis. However, 10-15% of patients develop distant metastases. The presence of metastases is an important prognostic factor that negatively affects...
3.
Baba K, Moretti J, Weinmann P, Senekowitsch-Schmidtke R, Ercan M
Met Based Drugs
. 2008 May;
6(6):329-36.
PMID: 18475909
The chemical structure of (99m)Tc-GSH has been estabilished using the (99)Tc isotope. Labeling of glutathione with technetium in the presence of stanous chloride gave a high yield result. In a...
4.
Ndoye O, Ba M, Niang E, Rebillard O, Tofighi M, Veinmann P, et al.
Dakar Med
. 2007 Jul;
50(3):157-9.
PMID: 17633001
Introduction: Diagnosis of carcinomas of unknown primary site has proved to be difficult for many reasons. Patient And Methods: In this study, case in which cerebral metastasis is confirmed by...
5.
Onen F, Feugeas M, De Marco G, Baron G, Ravaud P, Legrain S, et al.
J Neuroradiol
. 2005 Mar;
32(1):3-9.
PMID: 15798607
Rationale And Objectives: To investigate the relationship between CSF dynamics and risk of falls of unknown origin in the elderly. Population And Methods: Phase contrast MR studies allowed CSF aqueductal...
6.
Kothan S, Dechsupa S, Leger G, Moretti J, Vergote J, Mankhetkorn S
Can J Physiol Pharmacol
. 2005 Jan;
82(12):1084-90.
PMID: 15644950
Natural products from plants such as flavonoids are potential drugs to overcome multidrug resistance (MDR) in cancer treatments. However, their modes of action are still unclear. In this study, the...
7.
Bihan H, Becker K, Snider R, Nylen E, Vittaz L, Lauret C, et al.
Thyroid
. 2003 Oct;
13(8):819-22.
PMID: 14558925
Design: The hormonal serum marker for the presence and course of patients with medullary thyroid cancer (MTC) is the mature calcitonin (CT) peptide. Other CALC-1 gene products such as the...
8.
Bourguet P, Blanc-Vincent M, Boneu A, Bosquet L, Chauffert B, Corone C, et al.
Br J Cancer
. 2003 Aug;
89 Suppl 1:S84-91.
PMID: 12915907
No abstract available.
9.
Burak Z, Ersoy O, Moretti J, Erinc R, Ozcan Z, Dirlik A, et al.
Eur J Nucl Med
. 2001 Oct;
28(9):1341-50.
PMID: 11585293
The occurrence of multidrug resistance (MDR), which is in part due to the overexpression of P-glycoprotein (Pgp), is a major problem in neoadjuvant therapy of malignant musculoskeletal tumours. The aim...
10.
Vergote J, Di Benedetto M, Moretti J, Azaloux H, Kouyoumdjian J, Kraemer M, et al.
Cell Mol Biol (Noisy-le-grand)
. 2001 Jul;
47(3):467-71.
PMID: 11441954
Defects in key components of apoptotic pathways provide a survival advantage to cells and have been implicated as important factors in tumorogenesis. As therapeutic drug-induced apoptosis is a key component...